Related Experiment Video
Updated: Jul 29, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
The capsaicin VR1 receptor mediates substance P release in toxin A-induced enteritis in rats
1Department of Cell Biology, Box 3709, Duke University Medical Center and Durham V. A. Medical Center, Durham, North Carolina 27710, USA.
Abstract:
The mechanism by which Clostridium difficile toxin A causes substance P (SP) release and subsequent inflammation in the rat ileum is unknown. Pretreatment with the vanilloid receptor subtype 1 (VR1) antagonist, capsazepine, before toxin A administration significantly inhibited toxin A-induced SP release and intestinal inflammation. Intraluminal administration of the VR1 agonist capsaicin caused intestinal inflammation similar to the effects of toxin A. Pretreatment with capsazepine before capsaicin administration also significantly inhibited capsaicin-induced intestinal inflammation. These results suggest that intraluminal toxin A causes SP release from primary sensory neurons via stimulation of VR1 receptors resulting in intestinal inflammation.
Insights
Clostridium difficile toxin A triggers substance P release and gut inflammation via vanilloid receptor subtype 1 (VR1) activation. Blocking VR1 with capsazepine inhibits this inflammatory response in rats.
Area of Science:
- Gastroenterology
- Neuroscience
- Immunology
Background:
- Clostridium difficile toxin A is a major cause of antibiotic-associated diarrhea and intestinal inflammation.
- The precise mechanism of toxin A-induced inflammation, particularly the role of substance P (SP) and sensory neurons, remains unclear.
Purpose of the Study:
- To investigate the role of the vanilloid receptor subtype 1 (VR1) in mediating toxin A-induced substance P release and intestinal inflammation in a rat model.
Main Methods:
- Rats were pretreated with capsazepine, a VR1 antagonist, or vehicle before administration of Clostridium difficile toxin A.
- Intraluminal administration of capsaicin, a VR1 agonist, was used to mimic toxin A effects.
- Substance P levels and inflammatory markers in the rat ileum were assessed.
Main Results:
- Capsazepine pretreatment significantly inhibited toxin A-induced SP release and intestinal inflammation.
- Intraluminal capsaicin administration induced inflammation comparable to toxin A.
- Capsazepine also inhibited capsaicin-induced intestinal inflammation.
Conclusions:
- Clostridium difficile toxin A stimulates SP release from primary sensory neurons through the activation of VR1 receptors.
- VR1 receptor activation is a key pathway in toxin A-induced intestinal inflammation.
- Targeting VR1 receptors may offer a therapeutic strategy for Clostridium difficile-associated intestinal inflammation.

